ALPEK (ALPEKA) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
23 Jul, 2026Executive summary
Achieved strong operational performance and supply chain management, driving significant EBITDA growth and customer diversification amid global trade disruptions and higher freight costs.
Reported EBITDA rose 300% year-over-year to $407 million, with comparable EBITDA up 169% to $336 million in Q2 2026, supported by higher volumes and improved margins.
Operating free cash flow reached $127 million, and net debt was reduced to $1.66 billion, improving leverage to 2.2x.
Entered the second half of the year with a more resilient operating and financial position, supporting a raised 2026 EBITDA guidance.
Completed the sale of the Beaver Valley site, generating additional free cash flow and supporting debt reduction.
Financial highlights
Comparable EBITDA rose 169% year-over-year to $336 million; reported EBITDA reached $407 million, up 300% from last year, including a $66 million inventory gain.
Operating free cash flow totaled $127 million, with a 31% earnings-to-cash conversion rate.
Net debt reduced to $1.66 billion, with leverage ratio improved to 2.2x.
Total revenues reached $2.15 billion, up 27% QoQ and 28% YoY, driven by higher volumes and prices.
Quarterly volume increased to 1.18 million tons, up 6% sequentially and 5% year-over-year.
Outlook and guidance
Raised 2026 comparable EBITDA guidance to $750–$800 million and operating free cash flow to $300–$350 million.
CapEx guidance for 2026 set at $150 million, supporting polypropylene and PET projects.
Guidance assumes normalization of margins and freight rates in H2, but still above original expectations.
Guidance excludes potential monetization of non-strategic assets and additional U.S. tariffs, which could provide upside.
No dividend resumption expected in 2026 to prioritize financial flexibility and deleveraging.
Latest events from ALPEK
- 2025 EBITDA dropped 30% to $489M, but free cash flow rose 57%; 2026 outlook targets $450–$500M EBITDA.ALPEKA
Q4 20258 Jul 2026 - 1Q25 volume and EBITDA fell on overcapacity, but strategic initiatives and cash flow improved.ALPEKA
Q1 202530 Jun 2026 - EBITDA surged 50% sequentially, with improved leverage and strong segment performance.ALPEKA
Q1 20266 May 2026 - Stable volumes, $75M cost savings, and lower leverage support 2024 guidance.ALPEKA
Q2 20242 Feb 2026 - Q3 delivered record EBITDA, raised guidance, and progress on spin-off and cost savings.ALPEKA
Q3 202418 Jan 2026 - 2024 EBITDA beat guidance, cost savings hit $75M, and leverage improved to 2.9x.ALPEKA
Q4 202416 Dec 2025 - Lower earnings and revised guidance amid global oversupply, tariffs, and operational disruptions.ALPEKA
Q2 202516 Nov 2025 - EBITDA and cash flow rose sequentially, but oversupply and lower prices pressured guidance.ALPEKA
Q3 202523 Oct 2025